Novilytic Named a Finalist in BioTools Innovator’s 2025 Competition

WEST LAFAYETTE, Ind. (October 30, 2025) – Novilytic, an innovator in molecular recognition technology, today announced it has been named a finalist in BioTools Innovator’s (BTI) 2025 Competition.

Selected from a global pool of more than 600 applicants and distinguished among this year’s 31-company cohort, Novilytic will compete live at the BioTools Innovator Capstone Event on November 18 in San Diego for the $300,000 in cash prizes and the title of BioTools Innovator 2025 Winner.

At the Capstone Event, finalists will pitch their innovations, field questions from a panel of industry experts, and face a real-time audience vote that determines the winner. The event also features keynote presentations, panel discussions, and a showcase of the entire BioTools Innovator 2025 cohort.

The Novilytic Proteometer simplifies biopharmaceutical analytics.  Specifically, current analytical testing used in R&D relies on dated technology that requires multiple personnel, dozens of consumables, and five to six expensive instruments to obtain critical data. 

Novilytic’s Proteometer provides the same answers utilizing just one person, their existing instrument, and one Proteometer consumable kit.

“We’re honored to be recognized as a finalist among such an incredible collection of companies and scientific minds,” said Paul Dreier, CEO, Novilytic. “This recognition showcases the potential the Proteometer holds for transformational change in the early stages of drug development. BioTool’s appreciation, and more importantly, their support and mentorship throughout this process have provided decades of knowledge and growth in just a few short months. We are immensely thankful to the BioTools Innovator team and this cohort.”

Now in its fifth year, BioTools Innovator selected its 2025 cohort from more than 600 applicants worldwide, representing the top 7% of companies in the field. Participants received personalized mentorship, strategic guidance, and access to a global network of investors, industry leaders, and advisors.

About Novilytic

Novilytic simplifies bioanalytics research for protein-based pharmaceuticals. Their Proteometer product line is revolutionizing drug development and clone selection by eliminating sample preparation steps that were previously industry-standard. Their transformational and patented technology fundamentally streamlines biopharmaceutical analysis enabling near-real-time molecular structure analysis. This reduces the time and cost of drug development, ultimately helping to bring lifesaving treatments to the market faster. For more information, visit Novilytic.com.

About BioTools Innovator

Based in Los Angeles, BioTools Innovator was established to advance cutting-edge research and improve human health by accelerating the growth of a broad spectrum of life science tools and diagnostics. BioTools Innovator matches industry leaders with innovative early-stage and emerging growth biotechnology-focused companies for mentorship and support.

BioTools Innovator is powered by MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. To date, MTI alumni have collectively brought over 400 products to market and raised $10+ billion in follow-on funding. For more information about BioTools Innovator, visit the website and follow the organization on LinkedIn.

###

Media Contact: Ryan Simpson, Director of Marketing, Novilytic, rsimpson@novilytic.com